Symbols

TDOC

Teladoc Health·NYSE

--(--)

TDOC fundamentals

TDOC Q4 2025 Earnings

Teladoc Health (TDOC) released its earnings on Feb 25, 2026: revenue was 642.27M (YoY +0.28%), beat estimates; EPS was -0.14 (YoY +50.00%), beat estimates.

Revenue / YoY

642.27M

+0.28%

EPS / YoY

-0.14

+50.00%

Report date

Feb 25, 2026

TDOC Earnings Call Summary for Q4,2025

Revenue Stability: Q4 2025 revenue flat YoY at $642 million, with full-year decline of 1.5% to $2.53 billion.
Profit Margins: Adjusted EBITDA margin of 13% in Q4, up from 11.1% full-year 2024.
AI and Growth: Launch of Pulse AI platform to enhance clinical outcomes, with 2026 guidance for Integrated Care EBITDA margin expansion.
BetterHelp Transformation: Insurance-based revenue targeting $75M-$90M in 2026, with session growth exceeding 1,200/day.
Debt Management: Plans to reduce net debt through 2027 convertible debt refinancing, supporting financial flexibility.

Earnings

EPS

Revenue

Revenue & Expenses

TDOC has released its 2025 Q4 earnings report, with revenue of 642.27M, reflecting a YoY change of 0.28%, and net profit of -25.14M, showing a YoY change of 48.06%. The Sankey diagram below clearly presents TDOC's revenue sources and cost distribution.

Key Indicators

Teladoc Health (TDOC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Teladoc Health (TDOC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Teladoc Health (TDOC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Teladoc Health (TDOC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown